Milestones & Momentum
News & Updates.
August 05, 2026
CellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for Next-Generation Solid Tumor Immunotherapy
Learn More
February 27, 2026
Tidewave Bio Appoints Prof. Alexander M.M. Eggermont, MD, PhD, as Head of Clinical Advisory Board
Learn More
August 28, 2025
Tidewave Bio Completes FDA INTERACT Meeting for TBC-1, a Universal Cell Therapy Platform in Solid Tumors
Learn More
August 07, 2025
Tidewave Bio Reaches Key Regulatory Milestone with FDA INTERACT Meeting Scheduled for August 2025
Learn More
October 5–7, 2026
Cell & Gene Meeting on the Mesa
Learn More
June 22-25, 2026
BIO International Convention 2026
Learn More
FEBRUARY 24 – 26, 2026
Biocom global partnering meeting 2026
Learn More
February 09-12, 2026
Advanced Therapies Week
Learn More
